Hepatitis is a viral infection that causes an inflammation in the liver. Antiviral drug tenofovir given to pregnant women in their second or third trimester can prevent mother to child transmission of the hepatitis B virus (HBV), finds a recent study.
Universal vaccination of newborn babies has brought transmission rates down to 10-30%. In their Alimentary Pharmacology & Therapeutics analysis of data from five controlled trials, Dr. Ji Hoon Kim and his colleagues found that the risk of maternal transmission to the baby is further reduced, down to only 3% (77% reduction of transmission), when the mother receives the antiviral drug tenofovir during pregnancy.
‘Antiviral drug tenofovir when given to pregnant women may prevent the mother to child transmission of hepatitis B virus (HBV).’
Chronic HBV infection affects approximately 240 million people worldwide. Without treatment, it is transmitted from mother to baby in about 90% of births, often causing liver disease as the child grows up. More than 600,000 people die annually because of HBV complications.